Letermovir prophylaxis guided by cytomegalovirus cell-mediated immunity improves the outcomes of allogeneic hematopoietic stem cell transplant recipients.

Prevymis (letermovir) - Merck (MSD)

http://www.ncbi.nlm.nih.gov/pubmed/40705849

Chuanhe Jiang; Haiyang Lu; Jiayu Huang; Jingtao Huang; Jun Zhu; Luxiang Wang; Meijuan Huang; Qi Chen; Su Li; Xiaojia Guo; Xiaoxia Hu; Yang Cao; Yang He; Zengkai Pan; Zilu Zhang

Jul 24, 2025